Published on in Vol 10, No 12 (2021): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/32653, first published .
Exploring the Effects of In-App Components on Engagement With a Symptom-Tracking Platform Among Participants With Major Depressive Disorder (RADAR-Engage): Protocol for a 2-Armed Randomized Controlled Trial

Exploring the Effects of In-App Components on Engagement With a Symptom-Tracking Platform Among Participants With Major Depressive Disorder (RADAR-Engage): Protocol for a 2-Armed Randomized Controlled Trial

Exploring the Effects of In-App Components on Engagement With a Symptom-Tracking Platform Among Participants With Major Depressive Disorder (RADAR-Engage): Protocol for a 2-Armed Randomized Controlled Trial

Journals

  1. White K, Carr E, Leightley D, Matcham F, Conde P, Ranjan Y, Simblett S, Dawe-Lane E, Williams L, Henderson C, Hotopf M. Engagement With a Remote Symptom-Tracking Platform Among Participants With Major Depressive Disorder: Randomized Controlled Trial. JMIR mHealth and uHealth 2024;12:e44214 View
  2. Chan G, Nwagu C, Odenigbo I, Alslaity A, Orji R. The Shape of Mobile Health: A Systematic Review of Health Visualization on Mobile Devices. International Journal of Human–Computer Interaction 2024:1 View
  3. Hoppe I, Watson S, Kemp C, Turnbull F, Davies F, Gibson J, Azim L, Wall L, Ahuja N, Al‐Ashmori S, Keys S, Kabir T, Chew‐Graham C. Aripiprazole/Sertraline Combination: Clinical and Cost‐Effectiveness in Comparison With Quetiapine for the Treatment of Bipolar Depression (ASCEnD Trial)—Protocol for a Nested Qualitative Study. Health Expectations 2024;27(5) View